Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Department of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul, 02447, Republic of Korea.
Exp Mol Med. 2024 Apr;56(4):836-849. doi: 10.1038/s12276-024-01201-6. Epub 2024 Apr 1.
Exosomes, which are nanosized vesicles secreted by cells, are attracting increasing interest in the field of biomedical research due to their unique properties, including biocompatibility, cargo loading capacity, and deep tissue penetration. They serve as natural signaling agents in intercellular communication, and their inherent ability to carry proteins, lipids, and nucleic acids endows them with remarkable therapeutic potential. Thus, exosomes can be exploited for diverse therapeutic applications, including chemotherapy, gene therapy, and photothermal therapy. Moreover, their capacity for homotypic targeting and self-recognition provides opportunities for personalized medicine. Despite their advantages as novel therapeutic agents, there are several challenges in optimizing cargo loading efficiency and structural stability and in defining exosome origins. Future research should include the development of large-scale, quality-controllable production methods, the refinement of drug loading strategies, and extensive in vivo studies and clinical trials. Despite the unresolved difficulties, the use of exosomes as efficient, stable, and safe therapeutic delivery systems is an interesting area in biomedical research. Therefore, this review describes exosomes and summarizes cutting-edge studies published in high-impact journals that have introduced novel or enhanced therapeutic effects using exosomes as a drug delivery system in the past 2 years. We provide an informative overview of the current state of exosome research, highlighting the unique properties and therapeutic applications of exosomes. We also emphasize challenges and future directions, underscoring the importance of addressing key issues in the field. With this review, we encourage researchers to further develop exosome-based drugs for clinical application, as such drugs may be among the most promising next-generation therapeutics.
外泌体是细胞分泌的纳米囊泡,由于其独特的性质,包括生物相容性、载药能力和深组织穿透性,在生物医学研究领域引起了越来越多的关注。它们作为细胞间通讯的天然信号分子,其内在携带蛋白质、脂质和核酸的能力赋予了它们显著的治疗潜力。因此,外泌体可用于多种治疗应用,包括化疗、基因治疗和光热治疗。此外,它们的同源靶向和自我识别能力为个性化医学提供了机会。尽管作为新型治疗剂具有优势,但在外泌体的载药效率和结构稳定性的优化以及外泌体起源的定义方面仍存在一些挑战。未来的研究应包括开发大规模、质量可控的生产方法、改进药物加载策略,以及广泛的体内研究和临床试验。尽管存在未解决的困难,但将外泌体作为高效、稳定和安全的治疗性药物输送系统是生物医学研究中一个有趣的领域。因此,本综述描述了外泌体,并总结了过去 2 年中在高影响力期刊上发表的、利用外泌体作为药物输送系统的新型或增强治疗效果的最新研究。我们提供了外泌体研究现状的信息性概述,强调了外泌体的独特性质和治疗应用。我们还强调了挑战和未来方向,突出了解决该领域关键问题的重要性。通过本综述,我们鼓励研究人员进一步开发基于外泌体的药物用于临床应用,因为这些药物可能是最有前途的下一代治疗方法之一。